Download PDF

1. Company Snapshot

1.a. Company Description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.


In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools.Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions.Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership.


The company serves integrated health systems, post-acute providers, and payer organizations.National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Show Full description

1.b. Last Insights on NRC

Negative drivers behind National Research Corporation's recent performance include rising costs and higher interest expenses, which led to a decline in Q4 EPS to 28 cents despite revenue growth. The company's net indebtedness also increased, and revenue fell short of the previous year's quarter, dropping to approximately $36.9 million. Additionally, the company's Q4 earnings release highlighted these challenges, which may impact its future financial performance.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

3. NewsRoom

Card image cap

Hadron Energy Receives Nuclear Regulatory Commission Acceptance of Its Quality Assurance Program Description Topical Report

Dec -03

Card image cap

NRC Health Partners with Mosaic Life Care to Advance Patient Experience Across the Midwest

Dec -02

Card image cap

NRC Health Appoints David Burik as Executive Vice President, Strategic Insights

Nov -20

Card image cap

NRC Health Partners with BJC HealthCare to Advance Experience Excellence Across a Unified Network

Nov -13

Card image cap

Nuclear startup that sued NRC raises $130 million with backing from Anduril's Palmer Luckey and senior Palantir executive

Nov -10

Card image cap

North Mississippi Health Services Chooses NRC Health to Elevate Care Experiences and Community Engagement

Nov -06

Card image cap

National Research (NASDAQ:NRC) and TransUnion (NYSE:TRU) Financial Survey

Nov -04

Card image cap

NRC Stock Up 12% Despite Q3 Earnings Down Y/Y on Rising Interest Costs

Oct -31

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (15.10%)

6. Segments

Analytics and Insights

Expected Growth: 15.1%

Growing demand for patient-centric care, increasing adoption of digital healthcare technologies, and need for data-driven decision making are driving the analytics and insights market growth.

7. Detailed Products

Market Insights

National Research Corporation's Market Insights provides actionable data and analytics to help healthcare organizations understand patient preferences, behaviors, and opinions.

Transparency

Transparency is a patient engagement platform that provides patients with personalized, easy-to-understand quality and satisfaction information about healthcare providers.

NRC Health

NRC Health is a comprehensive patient engagement and satisfaction platform that helps healthcare organizations improve patient experience and loyalty.

Oncology Insights

Oncology Insights provides cancer centers with patient-centered data and analytics to improve patient satisfaction, loyalty, and outcomes.

Patient Voice

Patient Voice is a real-time patient feedback platform that helps healthcare organizations improve patient experience and loyalty.

8. National Research Corporation's Porter Forces

Forces Ranking

Threat Of Substitutes

National Research Corporation faces moderate threat from substitutes, as customers have limited alternatives for its specialized research services.

Bargaining Power Of Customers

National Research Corporation's customers have limited bargaining power due to the company's specialized services and lack of direct competition.

Bargaining Power Of Suppliers

National Research Corporation's suppliers have moderate bargaining power, as the company relies on specialized vendors for its research services.

Threat Of New Entrants

National Research Corporation faces low threat from new entrants, as the industry requires significant expertise and resources to enter.

Intensity Of Rivalry

National Research Corporation operates in a highly competitive industry, with several established players competing for market share.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 43.24%
Debt Cost 4.73%
Equity Weight 56.76%
Equity Cost 6.29%
WACC 5.62%
Leverage 76.17%

11. Quality Control: National Research Corporation passed 5 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Premier

A-Score: 5.6/10

Value: 4.0

Growth: 2.1

Quality: 5.2

Yield: 5.0

Momentum: 9.5

Volatility: 8.0

1-Year Total Return ->

Stock-Card
HealthStream

A-Score: 4.8/10

Value: 3.7

Growth: 5.2

Quality: 6.9

Yield: 0.0

Momentum: 4.0

Volatility: 8.7

1-Year Total Return ->

Stock-Card
Forian

A-Score: 4.3/10

Value: 6.0

Growth: 6.4

Quality: 5.5

Yield: 0.0

Momentum: 6.0

Volatility: 1.7

1-Year Total Return ->

Stock-Card
National Research

A-Score: 4.0/10

Value: 3.4

Growth: 3.6

Quality: 6.0

Yield: 6.0

Momentum: 0.5

Volatility: 4.3

1-Year Total Return ->

Stock-Card
GeneDx

A-Score: 3.4/10

Value: 0.2

Growth: 4.3

Quality: 5.3

Yield: 0.0

Momentum: 9.5

Volatility: 1.0

1-Year Total Return ->

Stock-Card
Simulations Plus

A-Score: 3.0/10

Value: 5.6

Growth: 5.7

Quality: 4.2

Yield: 0.0

Momentum: 0.0

Volatility: 2.3

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

15.94$

Current Price

15.94$

Potential

-0.00%

Expected Cash-Flows